Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Oasis Network Price Predictions: Where Will a Coinbase Listing Take the ROSE Crypto?

Today, interest around Oasis Network price predictions is building as Coinbase announces support for Oasis, with trading starting tomorrow.

Volt Inu V2 Price Predictions: Where Will the Red-Hot VOLT Crypto Go Next?

Here's why investors are growing increasingly interested around expert Volt Inu V2 price predictions in today's market.

Why Is Sunshine Biopharma (SBFM) Stock Up Today?

Today, investors in Sunshine Biopharma and SBFM stock are getting a huge boost from news that the company filed a patent for a key drug.

Why Is Lexaria Bioscience (LEXX) Stock Up Today?

Today, investors in Lexaria Bioscience and LEXX stock are seeing impressive gains as investors price a key catalyst into shares.

Twitter (TWTR) Stock Could Crash 20%. Here’s Why.

Today, investors in TWTR stock have seen incredible volatility as investors price in a buyout offer for Twitter from Elon Musk.